UTHR · UNITED THERAPEUTICS Corp · Executive Compensation
$586.15
-5.02 (-0.85%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$25.18B
Shares
42.59M
Volume · Nov 16
165.24K
Avg daily vol (3M)
700.23K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Martine Rothblatt | Chairman and Chief Executive Officer | $15,627,537 |
| Michael Benkowitz | President and Chief Operating Officer | $8,383,194 |
| Paul Mahon | Executive Vice President and General Counsel | $7,564,551 |
| James Edgemond | Chief Financial Officer and Treasurer | $6,216,459 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Martine Rothblatt | Chairman and Chief Executive Officer | $16,036,300 |
| Michael Benkowitz | President and Chief Operating Officer | $6,609,258 |
| Paul Mahon | Executive Vice President and General Counsel | $5,297,542 |
| James Edgemond | Chief Financial Officer and Treasurer | $5,242,729 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Martine Rothblatt | Chairman and Chief Executive Officer | $17,933,401 |
| Paul Mahon | Executive Vice President and General Counsel | $6,871,506 |
| Michael Benkowitz | President and Chief Operating Officer | $6,517,529 |
| James Edgemond | Chief Financial Officer and Treasurer | $5,053,082 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Victor Dzau, M.D. | member of the Board | Appointed | 2026-07-23 |
| Kevin Tracey | Director | Appointed | 2026-06-29 |
| Tommy Thompson | Director | Appointed | 2026-06-29 |
| Louis Sullivan | Director | Appointed | 2026-06-29 |
| Christopher Patusky | Director | Appointed | 2026-06-29 |
| Martine Rothblatt | Director | Appointed | 2026-06-29 |
| Judy Olian | Director | Appointed | 2026-06-29 |
| Linda Maxwell | Director | Appointed | 2026-06-29 |
| Nilda Mesa | Director | Appointed | 2026-06-29 |
| Jan Malcolm | Director |
Already on the board
Since at least 2024: re-election or new board role
|
2026-06-29 |
| Ray Kurzweil | Director | Appointed | 2026-06-29 |
| Richard Giltner | Director | Appointed | 2026-06-29 |
| Christopher Causey | Director | Appointed | 2026-06-29 |
| Kevin J. Tracey | Board of Directors | Appointed | 2026-01-22 |
| Kevin J. Tracey, M.D. | member of the Board | Appointed | 2026-01-22 |
| Tommy Thompson | director | Appointed | 2025-06-27 |
| Louis Sullivan | director | Appointed | 2025-06-27 |
| Martine Rothblatt | director | Appointed | 2025-06-27 |
| Christopher Patusky | director | Appointed | 2025-06-27 |
| Judy Olian | director | Appointed | 2025-06-27 |
| Nilda Mesa | director | Appointed | 2025-06-27 |
| Linda Maxwell | director | Appointed | 2025-06-27 |
| Ray Kurzweil | director | Appointed | 2025-06-27 |
| Jan Malcolm | director | Appointed | 2025-06-27 |
| Richard Giltner | director | Appointed | 2025-06-27 |
Leadership
- Christopher Causey Board Member
- Christopher Patusky Board Member
- James Edgemond Board Member
- Jan Malcolm Board Member
- Judy Olian Board Member
- Katherine Klein Board Member
- Kevin J. Tracey Board Member
- Kevin J. Tracey, M.D. Board Member
- Kevin Tracey Board Member
- Linda Maxwell Board Member
- Linda Maxwell, M.D. Board Member
- Louis Sullivan Board Member
- Martine Rothblatt Board Member
- Michael Benkowitz Board Member
- Nilda Mesa Board Member
- Paul Mahon Board Member
- Ray Kurzweil Board Member
- Raymond Dwek Board Member
- Richard Giltner Board Member
- Tommy Thompson Board Member
- Victor Dzau Board Member
- Victor Dzau, M.D. Board Member
Key facts
CIK
1082554
CUSIP
91307C102
13F (30d)
647 filings
596 filers
Visit website
Investor relations